Novo Nordisk : NVO

All Novo Nordisk Articles

151 Articles

Rich Duprey | Oct 22, 2025 at 11:48 AM EDT

Market Meltdown Coming? These 2 ETFs Are Ready to Surge If Stocks Tank

The U.S. stock market has delivered impressive gains for over a decade, but warning signs of a potential downturn are…

Rich Duprey | Oct 17, 2025 at 11:05 AM EDT

Is Trump Going to Kill the GLP-1 Cash Cow?

The Boom That Built Billion-Dollar Empires GLP-1 drugs have reshaped the pharmaceutical landscape, turning obesity and diabetes treatments into massive…

Rich Duprey | Oct 1, 2025 at 10:47 AM EDT

100% Pharmaceutical Tariffs Are Here. Time to Buy These 3 Drugmakers

Starting today, the U.S. imposed 100% tariffs on imports of branded or patented pharmaceutical products that President Trump announced last…

Omor Ibne Ehsan | Sep 17, 2025 at 10:28 AM EDT

3 Stocks Insiders Are Buying Non-Stop

Insider buying is one of the few market signals that does not hide behind algorithms or price targets. When a…

Omor Ibne Ehsan | Sep 2, 2025 at 3:45 PM EDT

Jim Cramer Says This “Ridiculously Cheap” Healthcare Stock is a Buy

Healthcare investing has felt like walking through quicksand this year. One moment, the sector looks ready to spring forward on…

Rich Duprey | Aug 27, 2025 at 8:23 AM EDT

Eli Lilly’s Obesity Pill Breakthrough Shakes Up $150 Billion Weight-Loss Race

A Fierce Battle for Weight-Loss Supremacy The weight-loss drug market has become a battleground, ignited by the runaway success of…

Rich Duprey | Aug 22, 2025 at 12:13 PM EDT

Novo Nordisk Roars Back: 6 Catalysts Driving the Pharma’s Path to Dominance

A Comeback Fueled by Resilience Danish pharmaceutical giant Novo Nordisk (NYSE:NVO | NVO Price Prediction) has been a trailblazer in…

Joel South | Aug 19, 2025 at 9:08 AM EDT

Stock Market Live August 19: S&P 500 (VOO) Rally Still on Hold Pending Fed Talk

This article will be updated throughout the day, so check back often for more daily updates. It’s a pretty slow…

Joel South | Aug 18, 2025 at 9:12 AM EDT

Stock Market Live August 18: S&P 500 (VOO) Rally Pauses After Inconclusive Russia Talks

This article will be updated throughout the day, so check back often for more daily updates. The S&P 500 closed…

Rich Duprey | Aug 6, 2025 at 11:35 AM EDT

There Is Only 1 GLP-1 Stock to Buy In 2025

Weighing the Options The introduction of Novo Nordisk’s (NYSE:NVO | NVO Price Prediction) Ozempic revolutionized the fight against obesity, shifting…

Rich Duprey | Jul 29, 2025 at 11:25 AM EDT

Ozempic Maker Novo Nordisk Is Plunging 20%. Time to Sell or Buy More?

Danish pharmaceutical giant Novo Nordisk (NYSE:NVO | NVO Price Prediction) is watching its stock plummet 20% in morning trading after…

Rich Duprey | Jul 24, 2025 at 10:22 AM EDT

Is Hims & Hers the Newest Meme Stock Darling?

Telehealth platform Hims & Hers Health (NYSE:HIMS) shot to the top of stock charts yesterday as shares soared 16% high…

Rich Duprey | Jul 16, 2025 at 10:55 AM EDT

3 Ridiculously Discounted Growth Stocks to Buy Now

Digging Into the Bargain Bin Investing in beaten-down stocks can be a savvy strategy for long-term wealth creation, as it…

Omor Ibne Ehsan | Jul 14, 2025 at 10:18 AM EDT

3 Dividend Growth Stocks to Turn $10,000 Into $50,000 by 2035

If you wish to turn $10,000 into $50,000 by 2035, you’re looking at a 400% gain over a 10-year horizon.…

John Seetoo | Jun 27, 2025 at 3:36 PM EDT

6 International Stocks to Buy in July

With over $5 trillion of new investment commitments to date, the U.S. is experiencing a business renaissance being incentivized by…

1 2 3 4 5 … 11

Novo Nordisk : NVO

All Novo Nordisk Articles

Market Meltdown Coming? These 2 ETFs Are Ready to Surge If Stocks Tank

Is Trump Going to Kill the GLP-1 Cash Cow?

100% Pharmaceutical Tariffs Are Here. Time to Buy These 3 Drugmakers

3 Stocks Insiders Are Buying Non-Stop

Jim Cramer Says This “Ridiculously Cheap” Healthcare Stock is a Buy

Eli Lilly’s Obesity Pill Breakthrough Shakes Up $150 Billion Weight-Loss Race

Novo Nordisk Roars Back: 6 Catalysts Driving the Pharma’s Path to Dominance

Stock Market Live August 19: S&P 500 (VOO) Rally Still on Hold Pending Fed Talk

Stock Market Live August 18: S&P 500 (VOO) Rally Pauses After Inconclusive Russia Talks

There Is Only 1 GLP-1 Stock to Buy In 2025

Ozempic Maker Novo Nordisk Is Plunging 20%. Time to Sell or Buy More?

Is Hims & Hers the Newest Meme Stock Darling?

3 Ridiculously Discounted Growth Stocks to Buy Now

3 Dividend Growth Stocks to Turn $10,000 Into $50,000 by 2035

6 International Stocks to Buy in July

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

Novo Nordisk : NVO

All Novo Nordisk Articles

Market Meltdown Coming? These 2 ETFs Are Ready to Surge If Stocks Tank

Is Trump Going to Kill the GLP-1 Cash Cow?

100% Pharmaceutical Tariffs Are Here. Time to Buy These 3 Drugmakers

3 Stocks Insiders Are Buying Non-Stop

Jim Cramer Says This “Ridiculously Cheap” Healthcare Stock is a Buy

Eli Lilly’s Obesity Pill Breakthrough Shakes Up $150 Billion Weight-Loss Race

Novo Nordisk Roars Back: 6 Catalysts Driving the Pharma’s Path to Dominance

Stock Market Live August 19: S&P 500 (VOO) Rally Still on Hold Pending Fed Talk

Stock Market Live August 18: S&P 500 (VOO) Rally Pauses After Inconclusive Russia Talks

There Is Only 1 GLP-1 Stock to Buy In 2025

Ozempic Maker Novo Nordisk Is Plunging 20%. Time to Sell or Buy More?

Is Hims & Hers the Newest Meme Stock Darling?

3 Ridiculously Discounted Growth Stocks to Buy Now

3 Dividend Growth Stocks to Turn $10,000 Into $50,000 by 2035

6 International Stocks to Buy in July

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

Featured Reads

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not